Dr. Govindan on the Future of EGFR-Mutant NSCLC

preview_player
Показать описание
Ramaswamy Govindan, MD, professor, Department of Medicine, Oncology Division, Medical Oncology, Washington University School of Medicine in St. Louis, discusses the future treatment landscape of EGFR-mutant non–small cell lung cancer (NSCLC).
Рекомендации по теме